Search News Archives
Follow us on
Conferences | Events
Lab Bulletin Media Partners
Optibrium Ltd

Optibrium Ltd

Optibrium Ltd

Products

Contact Optibrium Ltd


If you have not logged into the website then please enter your details below.

All articles from Optibrium Ltd

  Optibrium and University of Nottingham Collaborate on Innovative Teaching Programme

Optibrium™, a developer of software for drug discovery, has announced it had entered into a collaboration with the University of Nottingham, a pioneering research institution and university. Optibrium’s StarDrop™ software will be available to a number of 4th year MSci Chemistry project students at the University of Nottingham as part of their training in modern drug discovery to aid in the design of potential new candidate compounds for integrin inhibition in fibrotic diseases and malaria, as part of their collaboration with GSK....

 

  Novel deep learning drug discovery platform gets ÂŁ1 million innovation boost

Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward as Optibrium™, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project. The program will see Optibrium, which creates software to improve the efficiency and productivity of drug discovery, and Intellegens, a spin out from the University of Cambridge which is focused on a specific form of AI called ‘deep learning’, work with Medicines Discovery Catapult over the next two years...

 

  Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery

Optibrium™, a developer of software for drug discovery, has announced it had signed a collaboration agreement with Intellegens, a company developing novel artificial intelligence (AI) software. The collaboration will provide Optibrium clients with access to advanced, proprietary deep learning methods that will extend and improve predictive models to guide the more efficient design and selection of high quality drug candidates.

 

  Optibrium Introduces StarDrop 6.5

Optibrium

Novel features include modelling for drug metabolism prediction and virtual library enumeration. Enhanced data visualisation environment for more efficient data analysis and project management. Optibrium™, a developer of software for drug discovery, today announced the launch of version 6.5 of StarDrop™ that provides a complete platform for small molecule design...

 

  Optibrium Expands US and UK Operations

optibriumOptibrium, a developer of software for small molecule drug discovery, today announced it has appointed Dr. Scott Lyon as Director of Business Development and relocated its Headquarters and R&D facilities, to Cambridge Innovation Park, Cambridge, UK. Optibrium’s move to larger premises is driven by the company’s rapid recent growth and will accommodate future expansion plans as it accelerates its R&D pipeline and extends research into new technologies....

 

  Optibrium and Bugworks Sign Agreement for StarDrop License

Antimicrobial resistance Biopharma selects StarDrop to guide discovery of next generation of antibiotics

optibriumOptibrium™, a developer of software for small molecule discovery, and Bugworks Research Inc. (Bugworks), a company focused on discovering biopharmaceuticals for the treatment of critical and serious bacterial infections, today announced the signing of a two-year agreement to license Optibrium’s StarDrop™ software....

 

  Optibrium Introduces StarDrop 6.4 with Universal Pose Generation Interface

Adds seamless link to compound structure assessment in 3D docking and alignment models

optibriumOptibrium, a developer of software for small molecule drug discovery, today announced the launch of version 6.4 of the StarDrop™ platform. The latest release includes a universal Pose Generation Interface, which seamlessly links expertly prepared docking and alignment models with StarDrop’s comprehensive environment for small molecule design, optimisation and data analysis....

 

  Optibrium, Imperial College and DNDi Collaborate in Drug Development Programme for Neglected Diseases

Provides MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds

OptibriumOptibrium™, a developer of software for small molecule design and optimisation today announced it had entered into a collaboration with Imperial College London, the world leading science-based research institution and university, and Drugs for Neglected Diseases initiative (DNDi), a non-profit drug R&D organisation developing new treatments for neglected diseases....

 

  Optibrium and Goldfinch Bio Sign Agreement for StarDrop License

Goldfinch Bio’s researchers select StarDrop to guide successful drug discovery

OptibriumOptibrium, a developer of software for small molecule discovery, and Goldfinch Bio, a company focused on discovering and developing precision therapies to treat patients with kidney disease, today announced that the company has signed a multi-year agreement to license Optibrium’s StarDrop software....

 

  Lhasa and Optibrium Enter Research and Product Development Collaboration

Drug discovery software specialists combine expertise to extend studies into drug metabolism modelling

OptibriumOptibrium™ and Lhasa Limited (Lhasa), developers of software for small molecule property prediction, design and optimisation, announced today they have formed a collaborative partnership to research next generation drug metabolism modelling....

 

  Optibrium Signs Agreement with Zastra Innovations for Distribution in India

New partnership gives researchers improved access to Optibrium’s StarDrop with dedicated local support

OptibriumOptibrium™, a developer of software for small molecule design and optimisation, announced today that it has appointed Zastra Innovations (Zastra) to be its sole distributor in India for StarDrop™, the company’s flagship product. Zastra will provide researchers in India with the full suite of StarDrop software, combined with local access to expert technical and customer support....

 

  Optibrium and eMolecules Collaborate on Chemistry Data Integration in StarDrop

Combines eMolecules’ collection of commercially available chemicals with StarDrop’s data analysis and compound design capabilities in drug discovery

OptibriumOptibrium™, a developer of software for small molecule design and optimisation today announced a collaboration with eMolecules, the provider of a comprehensive chemical sourcing database. The collaboration provides StarDrop™ users with seamless access to eMolecules’ extensive collection of screening compounds and chemical building blocks, further extending StarDrop’s capabilities to guide compound selection and design...

 

  Optibrium and MolPort Collaborate to Improve Speed and Cost-Efficiency of Drug Discovery

Partnership combines MolPort’s 6.3 Million HTS Compounds with StarDrop’s data analysis and compound design capabilities

OptibriumOptibrium™, a developer of software for small molecule design and optimisation, today announced a collaboration with MolPort, the provider of a comprehensive chemicals database, marketplace and order fulfilment platform. The collaboration offers StarDrop™ users fully integrated access to MolPort’s drug discovery database of 6.3 million commercially available screening compounds....

 

  Optibrium and Collaborative Drug Discovery Partner on Integration of StarDrop with CDD Vault

Optibrium™ and Collaborative Drug Discovery (CDD), developers of software products and services for drug discovery and development, today announced a collaboration to integrate the StarDrop™ and CDD Vault® platforms.

OptibriumThis creates a seamless connection in real time between project data, securely held and managed in CDD Vault, and StarDrop’s unique compound design and optimisation capabilities.  Instant access to the latest assay and compound data, with which a project team can share, interpret and model their chemistry, will lead to better decisions and shorter project timelines. CDD Vault is a hosted biological and chemical database that securely manages project data...

 

  Optibrium Introduces Database Query Interface for StarDrop

Providing instant access to compound data to interpret, model and guide drug discovery decisions

optibriumOptibrium™, a developer of software for small molecule drug discovery and optimisation, today announced the commercial launch of a database Query Interface for users of the company’s StarDrop software. The new tool provides an adaptable interface between an organisation’s own research data management systems and StarDrop’s unique compound design and optimisation capabilities. Instant access to the latest data, with which a project team can...

 

  Optibrium and The Edge Collaborate on Integration of StarDrop with BioRails

Combination provides an enterprise platform for comprehensive data management, analysis and compound design in drug discovery

OptibriumOptibrium™ and The Edge Software Consultancy, developers of software products and services for drug discovery and development, today announced a collaboration to provide an integrated solution linking the StarDrop™ and BioRails™ platforms....

 

  Optibrium Signs Agreement for Global License of StarDrop

Optibrium, a developer of software for small molecule discovery, has announced that Janssen Research and Development has signed an agreement to license Optibrium’s StarDrop software.

The agreement will provide a global licence for StarDrop and eight of StarDrop’s optional plug-in modules.

OptibriumStarDrop is a software suite that helps researchers to deliver optimally balanced, successful compounds. It brings confidence and intuitive simplicity to decision making; guiding and validating the direction taken by project teams and which compounds are prioritized...

 

  Optibrium Supports Global Health through Academic and Not-for-Profit Consortium

Optibrium™, a developer of software for small molecule drug discovery and optimisation, today announced it will make its StarDropTM technology available to an international consortium of academic and not-for profit organisations.

OptibriumUnder the agreement, licensed access to StarDrop software will be provided to support drug discovery projects as part of a global health programme focused on developing new treatments for neglected diseases. Consortium partners are involved in projects to facilitate and speed up the development of therapies for the treatment of so-called “neglected” diseases such as leishmaniasis, sleeping sickness, Chagas disease...

 

  BioSolveIT and Optibrium Sign Collaboration Agreement

Partnership will deliver a link between 2D and 3D design on medicinal chemists’ desktops

optibriumOptibrium™, providers of software for compound optimisation, and chemoinformatics specialist BioSolveIT, today announced that they will collaborate to create seamlessly integrated data analysis, visualisation and simulation software for drug research. The two companies are known for their best-in-class prediction tools for selection and optimisation of potential therapeutics, where it is essential to recognise and resolve potential problems...

 

  Optibrium and Certara Collaborate on Integration of StarDrop and D360

Optibrium™ and Certara®, developers of software products and services for drug discovery and development, today announced a collaboration to provide their mutual customers with an integrated solution linking Optibrium’s StarDrop™ with Certara’s D360™ platform. 

optibriumThe combination of these two products enables researchers to combine the industry-leading self-service data access and analysis capabilities of D360, with StarDrop’s unique, interactive environment that guides compound selection and design decisions in drug discovery, helping project teams to identify high quality compounds more efficiently. D360 provides scientific data integration, access, analysis, and visualisation capabilities for...

 

  Optibrium and ChemAxon Announce Technology Collaboration

Interface between StarDrop and Plexus facilitates seamless access to both software platforms

OptibriumOptibrium™ and ChemAxon™, developers of software and cheminformatics solutions for drug discovery, today announced the results of a collaboration to integrate ChemAxon’s Plexus™ with Optibrium’s StarDrop™ software suite. The integration of these platforms further enables researchers to develop strategies for efficient, high quality compound library design. The StarDrop software platform from Optibrium facilitates multi-parameter optimisation...

 

  Optibrium and NextMove Software Announce Technology Collaboration

Automatic application of Matsy method for matched series analysis within StarDrop™ will guide compound optimisation in drug discovery

Optibrium Optibrium™ and NextMove Software, developers of software and chemoinformatics solutions for drug discovery, today announced an agreement to collaborate on the integration of NextMove Software’s Matsy technology with Optibrium’s StarDrop software suite.  The combination of these technologies will help guide scientists to quickly identify novel compounds based on matched molecular series analysis with a high chance of success...

 

  Optibrium Introduces the Latest Release of StarDrop Featuring Card View, a Unique Freeform Environment

StarDrop 6.0 gives researchers the freedom to explore and organise complex project data in a flexible and intuitive way

Optibrium logoOptibrium™, a developer of software for drug discovery, today announced the release of version 6.0 of its StarDrop™ software platform. This major new release introduces Card View™, an intuitive and highly flexible environment to view and interact with compound data in the context of discovery projects.  Card View provides a unique and highly visual way to interpret data on compounds and their relationships, clearly highlighting the best chemistries and...

 

  Optibrium and Lhasa Limited Collaborate to Bring High Level, Expert Toxicity Prediction to Chemists’ Desktops

New Derek™ module for StarDrop™ facilitates the efficient design and selection of safe, efficacious compounds in early drug discovery

New Derek™ module for StarDrop™Optibrium and Lhasa Limited, providers of software for compound design, selection and property prediction,today announce a technology collaboration agreement. Lhasa’s Derek Nexus™ platform for knowledge-based prediction of compound toxicity will be integratedas an optional plug-in module for Optibrium’s StarDrop software, that guides the design and selection of high quality compounds in drug discovery...

 

  StarDrop 5.3 Offers Intuitive Virtual Library Design

Optibrium extends StarDrop’s capabilities to guide the design of high quality compound libraries for drug discovery

StarDrop 5 3Optibrium™, developer of software solutions for drug discovery, today announces a new version of its StarDrop platform. Version 5.3 introduces new features focused on the design of virtual libraries, guided by StarDrop’s unique multi-parameter optimisation capabilities to prioritise compounds with the best balance of properties for synthesis and testing...

 

  Win a Trip to ACS Spring 2013 Meeting & Exposition With Optibrium Enter the StarDrop application note competition to be in with a chance 

optribriumOptibrium, developer of software solutions for drug discovery, today announces the launch of its application note competition offering StarDrop users the opportunity to win a trip to the American Chemical Society (ACS) Spring National Meeting & Exposition 2013 in New Orleans, Louisiana. For a chance to win, StarDrop users who use the software in their drug discovery projects are invited to submit an application note demonstrating their innovative use of StarDrop.

 

  Optibrium unveils the first output from its collaboration with Cresset optribriumOptibrium, developer of software solutions for drug discovery, today announces a new version of its StarDropTM platform. StarDrop 5.2 features a new plug-in module that provides users with access to Cresset's FieldAlignTM technology, which offers a unique, 3-dimensional insight into the biological activity of their compounds. This new development is the first result of the technology exchange between Optibrium and Cresset announced earlier this year, and adds another powerful tool to StarDrop that will enable chemists to understand the 3D structure activity relationship (SAR) of their chemistry in order to optimise their compounds...

 

  Cresset and Optibrium Announce Technology Collaboration Cresset BioMolecular Discovery LtdInnovative software and services provider Cresset, and Optibrium, a provider of software solutions for drug discovery, today announce an agreement to collaborate on the development of next-generation platforms. The innovative companies will work together, combining unique approaches to help drug discovery projects quickly identify novel, potent compounds with a high chance of success downstream...

 

  Optibrium Expands StarDrop Availability with Apple Mac Compatibility StarDrop 5.1Optibrium, a provider of software solutions for drug discovery, today launches StarDrop 5.1, an upgraded version of its innovative support tool which helps drug discovery scientists to guide key decisions in drug discovery and quickly achieve successful project outcomes. As a result of this upgrade, StarDrop's unique capabilities to guide the design and selection of high quality, novel compounds are now available on the Apple Mac, a reflection of the increasing popularity of Macs within the industry...

 

  Optibrium Announces Free Models to Predict Toxicity of Compounds StarDrop-ToxicityOptibrium, a provider of software solutions for drug discovery, announces the availability of a range of models to help predict the toxicity of potential new compounds. Optibrium has generated a range of Quantitative Structure Activity Relationship (QSAR) models of key toxicity endpoints, based on data made available by the US Environmental Protection Agency (EPA) as part of its Toxicity Evaluation Software Toolkit (T.E.S.T.). The toxicity prediction models were built with the Auto-Modeller module of the newly launched StarDrop 5 and are available to all StarDrop users free-of-charge...

 

  Optibrium to Unveil StarDrop 5 and Revolutionary Nova Module at ACS Spring 2011 optribriumOptibrium, a provider of software solutions for drug discovery, will be officially launching the next generation of StarDrop featuring the ground-breaking Nova module on booth #1121 at the American Chemical Society (ACS) National Exposition, 27-31 March, 2011, Anaheim, CA. This intuitive platform helps to guide scientists' decisions to quickly identify compounds with a high chance of success for their drug discovery project...

 

  New Paper from Optibrium and Tessella Illustrates Scientists’ Instincts Are Often Impaired by Human Cognitive Biases When Making Drug Discovery Decisions Optibrium, a provider of software solutions for drug discovery, and Tessella, the information technology and consulting services company and world leaders in digital preservation technology, today published a new paper highlighting that scientists' instincts may not always lead them to making good drug discovery decisions.

 

  Optibrium Secures 25 Accounts in First Year of Business Optibrium, a provider of software solutions for drug discovery, today celebrates two significant milestones: its first year of trading and signing its 25th customer. Based in Cambridge, UK, Optibrium has a global customer base ranging from top-ten pharma companies to small biotechs and academic groups, including Johnson & Johnson PR&D, Pfizer, Merck Serono, Teijin Pharma Ltd., Galapagos N.V., MRC Technology, The Campbell Family Institute for Breast Cancer Research and The University of Dundee.

 

  Optibrium Showcases StarVue at ACS Spring 2010 Optibrium, a provider of software solutions for drug discovery, will be showcasing StarVueTM on booth #121 at 2010 Spring ACS National Meeting and Exposition, March 21-25, San Francisco, CA, USA.